- ISIN
- US14161W1053
- CUSIP
- 14161W105
- Sector
- Communication Services
- Industry
- Internet Content & Information
- IPO Date
- Feb 9, 2018
Highlights
- Market Cap
- $35.68M
- Enterprise Value
- $211.50M
- EPS (TTM)
- -$1.77
- Total Revenue (TTM)
- $205.69M
- Gross Profit (TTM)
- $79.92M
- EBITDA (TTM)
- -$74.62M
- Year Range
- $0.57 - $3.28
- Target Price
- $1.00
- ROA (TTM)
- -35.88%
- ROE (TTM)
- 2,365.38%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
CDLX Performance Chart
Cardlytics, Inc. (CDLX) is down 43.5% since the beginning of the year. At $1 per share, CDLX is trading 80.2% below its 52-week high of $3. Investors who bought $1,000 worth of CDLX shares 5 years ago would now be looking at an investment worth $7.
Loading charts...
Returns By Period
Cardlytics, Inc. (CDLX) has returned -43.48% so far this year and -61.76% over the past 12 months.
Cardlytics, Inc.
- 1D
- -0.23%
- 1M
- -26.15%
- YTD
- -43.48%
- 6M
- -47.15%
- 1Y
- -61.76%
- 3Y*
- -51.54%
- 5Y*
- -63.40%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
CDLX Monthly Returns History
Based on dividend-adjusted daily data since Feb 9, 2018, CDLX's average daily return is +0.11%, while the average monthly return is +1.55%. At this rate, an investment would double in approximately 3.8 years.
Historically, 42% of months were positive and 58% were negative. The best month was Sep 2025 with a return of +138.2%, while the worst month was Mar 2020 at -56.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, CDLX closed higher 48% of trading days. The best single day was Sep 18, 2025 with a return of +92.7%, while the worst single day was Aug 8, 2024 at -57.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.78% | -10.78% | 21.51% | -14.53% | -24.80% | -3.68% | -43.48% | ||||||
| 2025 | -17.52% | -14.05% | -30.80% | -20.88% | 25.69% | -9.12% | 24.01% | -50.00% | 138.24% | -20.16% | -36.08% | -7.26% | -69.00% |
| 2024 | -17.05% | 8.51% | 74.79% | -15.46% | -28.49% | -6.28% | 0.97% | -52.83% | -18.16% | 34.69% | -5.57% | -8.85% | -59.72% |
| 2023 | 29.76% | -27.33% | -37.71% | 91.16% | -20.34% | 22.24% | 84.65% | 42.76% | -0.96% | -24.91% | -35.75% | 15.70% | 59.34% |
| 2022 | 1.53% | -13.56% | -5.21% | -37.92% | -24.08% | -13.89% | -38.14% | -4.06% | -29.00% | 0.32% | -52.39% | 28.73% | -91.25% |
| 2021 | -14.36% | 8.31% | -17.16% | 25.37% | -22.53% | 19.13% | -0.76% | -27.93% | -7.53% | -6.29% | -14.09% | -2.20% | -53.71% |
Benchmark Metrics
Cardlytics, Inc. has an annualized alpha of -0.69%, beta of 1.97, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since February 12, 2018.
- This stock participated in 159.95% of S&P 500 Index downside but only -3.89% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -0.69%
- Beta
- 1.97
- R²
- 0.11
- Upside Capture
- -3.89%
- Downside Capture
- 159.95%
Return for Risk
Risk / Return Rank
CDLX ranks 24 for risk / return — below 24% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Cardlytics, Inc. (CDLX) and compare them to S&P 500 Index.
| CDLX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.65 | ||
| Sortino ratioReturn per unit of downside risk | -3.03 | ||
| Omega ratioGain probability vs. loss probability | 1.00 | 1.41 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.77 | 2.93 | -3.69 |
| Martin ratioReturn relative to average drawdown | -1.07 | 13.52 | -14.59 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Cardlytics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cardlytics, Inc. was 99.62%, occurring on May 19, 2026. The portfolio has not yet recovered.
The current Cardlytics, Inc. drawdown is 99.59%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.62%May 2026 | 5y 3mo | — | 5y 3moFeb 2021 - now |
COVID crash2020 | -71.37%Mar 2020 | 1mo 2d | 7mo 22d | 8mo 24dFeb 2020 - Nov 2020 |
Rate-hike selloffLate 2018 | -62.39%Dec 2018 | 3mo 4d | 6mo 12d | 9mo 16dSep 2018 - Jul 2019 |
2018 bear market2018 | -28.75%Apr 2018 | 2mo | 11d | 2mo 11dFeb 2018 - May 2018 |
2018 bear market2018 | -28.43%Jul 2018 | 1mo 11d | 1mo 14d | 2mo 25dJun 2018 - Sep 2018 |
Drawdown Indicators
| CDLX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.62% | -56.78% | -42.84% |
Max Drawdown (1Y)Largest decline over 1 year | -80.90% | -9.10% | -71.80% |
Max Drawdown (3Y)Largest decline over 3 years | -97.06% | -18.90% | -78.16% |
Max Drawdown (5Y)Largest decline over 5 years | -99.55% | -25.43% | -74.12% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.59% | -0.74% | -98.85% |
Average DrawdownAverage peak-to-trough decline | -61.10% | -10.72% | -50.38% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 57.83% | 1.97% | +55.86% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Cardlytics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Cardlytics, Inc. is priced in the market compared to other companies in the Internet Content & Information industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CDLX relative to other companies in the Internet Content & Information industry. Currently, CDLX has a P/S ratio of 0.2. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with CDLX
Add Cardlytics, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with CDLX